| Product Code: ETC9561915 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Parkinsons Disease Treatment Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Parkinsons Disease Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Parkinsons Disease Treatment Market - Industry Life Cycle |
3.4 Sweden Parkinsons Disease Treatment Market - Porter's Five Forces |
3.5 Sweden Parkinsons Disease Treatment Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Sweden Parkinsons Disease Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Sweden Parkinsons Disease Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of Parkinson's disease in Sweden |
4.2.2 Technological advancements in treatment options |
4.2.3 Rising healthcare expenditure and government support for Parkinson's disease treatment |
4.3 Market Restraints |
4.3.1 High cost associated with Parkinson's disease treatment |
4.3.2 Side effects and limitations of current treatment options |
5 Sweden Parkinsons Disease Treatment Market Trends |
6 Sweden Parkinsons Disease Treatment Market, By Types |
6.1 Sweden Parkinsons Disease Treatment Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Sweden Parkinsons Disease Treatment Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Sweden Parkinsons Disease Treatment Market Revenues & Volume, By Carbidopa-Levodopa, 2021- 2031F |
6.1.4 Sweden Parkinsons Disease Treatment Market Revenues & Volume, By Dopamine Agonists, 2021- 2031F |
6.1.5 Sweden Parkinsons Disease Treatment Market Revenues & Volume, By MAO-B Inhibitors, 2021- 2031F |
6.1.6 Sweden Parkinsons Disease Treatment Market Revenues & Volume, By COMT Inhibitors, 2021- 2031F |
6.1.7 Sweden Parkinsons Disease Treatment Market Revenues & Volume, By Anticholinergics, 2021- 2031F |
6.1.8 Sweden Parkinsons Disease Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Sweden Parkinsons Disease Treatment Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Sweden Parkinsons Disease Treatment Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.2.3 Sweden Parkinsons Disease Treatment Market Revenues & Volume, By Specialty Pharmacy, 2021- 2031F |
6.2.4 Sweden Parkinsons Disease Treatment Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Sweden Parkinsons Disease Treatment Market Import-Export Trade Statistics |
7.1 Sweden Parkinsons Disease Treatment Market Export to Major Countries |
7.2 Sweden Parkinsons Disease Treatment Market Imports from Major Countries |
8 Sweden Parkinsons Disease Treatment Market Key Performance Indicators |
8.1 Average wait time for Parkinson's disease treatment |
8.2 Number of clinical trials for new treatment approaches |
8.3 Patient satisfaction with treatment options |
8.4 Rate of adoption of new technologies in Parkinson's disease treatment |
8.5 Number of healthcare professionals specializing in Parkinson's disease treatment |
9 Sweden Parkinsons Disease Treatment Market - Opportunity Assessment |
9.1 Sweden Parkinsons Disease Treatment Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Sweden Parkinsons Disease Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Sweden Parkinsons Disease Treatment Market - Competitive Landscape |
10.1 Sweden Parkinsons Disease Treatment Market Revenue Share, By Companies, 2024 |
10.2 Sweden Parkinsons Disease Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here